There’s emerging evidence that the allergy drug omalizumab may reduce severe allergic reactions for alpha-gal syndrome, a red meat allergy triggered by a tick bite.
There’s emerging evidence that the allergy drug omalizumab may reduce severe allergic reactions for alpha-gal syndrome, a red meat allergy triggered by a tick bite.
